tiprankstipranks
Advertisement
Advertisement

KSPHF Stock Latest News

Kissei Pharmaceutical Reports No Share Buybacks Yet Under 2026 Repurchase Program
Company AnnouncementsKissei Pharmaceutical Reports No Share Buybacks Yet Under 2026 Repurchase Program
15d ago
Kissei Faces EU Setback as EMA Backs Revocation of TAVNEOS Authorization
PremiumCompany Announcements
Kissei Faces EU Setback as EMA Backs Revocation of TAVNEOS Authorization
19d ago
Kissei Pharmaceutical Grants Restricted Stock to Board Members and Officers
PremiumCompany Announcements
Kissei Pharmaceutical Grants Restricted Stock to Board Members and Officers
25d ago
Kissei Pharmaceutical Sets Share Buyback Framework but Executes No Purchases in May
PremiumCompany Announcements
Kissei Pharmaceutical Sets Share Buyback Framework but Executes No Purchases in May
2M ago
Kissei Files Japan NDA for IDH1-Targeting AML Drug Olutasidenib
PremiumCompany Announcements
Kissei Files Japan NDA for IDH1-Targeting AML Drug Olutasidenib
2M ago
Kissei Tightens Safety Warnings on TAVNEOS After Serious Liver Risk Cases
PremiumCompany AnnouncementsKissei Tightens Safety Warnings on TAVNEOS After Serious Liver Risk Cases
2M ago
Kissei Restricts TAVNEOS Use in Japan After Global Safety and Data Concerns
Premium
Company Announcements
Kissei Restricts TAVNEOS Use in Japan After Global Safety and Data Concerns
2M ago
Kissei Pharmaceutical Posts Record Sales as R&D Investment and Overseas Growth Intensify
Premium
Company Announcements
Kissei Pharmaceutical Posts Record Sales as R&D Investment and Overseas Growth Intensify
2M ago
Kissei Pharmaceutical Launches ¥6 Billion Share Buyback and Cancellation Plan
PremiumCompany Announcements
Kissei Pharmaceutical Launches ¥6 Billion Share Buyback and Cancellation Plan
2M ago
Kissei Pharmaceutical Details FY2026 Results and R&D Pipeline in Supplementary Report
PremiumCompany Announcements
Kissei Pharmaceutical Details FY2026 Results and R&D Pipeline in Supplementary Report
2M ago
Kissei Pharmaceutical Swings to Operating Loss but Lifts Payouts and Eyes Profit Recovery
PremiumCompany Announcements
Kissei Pharmaceutical Swings to Operating Loss but Lifts Payouts and Eyes Profit Recovery
2M ago
KSPHF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
KSPHF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Kissei sublicenses AML drug olutasidenib to Orient EuroPharma in Taiwan
PremiumCompany AnnouncementsKissei sublicenses AML drug olutasidenib to Orient EuroPharma in Taiwan
3M ago
Kissei Pharmaceutical Names Research Chief Keiji Miyazawa as New President and COO
Premium
Company Announcements
Kissei Pharmaceutical Names Research Chief Keiji Miyazawa as New President and COO
3M ago
Kissei Launches Yselty in Japan, Expanding Global Uterine Fibroid Treatment Portfolio
Premium
Company Announcements
Kissei Launches Yselty in Japan, Expanding Global Uterine Fibroid Treatment Portfolio
4M ago
Kissei Pharmaceutical to Allocate ¥2.4 Billion in Treasury Shares to Employee Shareholding Plan
PremiumCompany Announcements
Kissei Pharmaceutical to Allocate ¥2.4 Billion in Treasury Shares to Employee Shareholding Plan
5M ago
Kissei Pharmaceutical Marks 80th Anniversary With Special Dividends and Higher Payout
PremiumCompany Announcements
Kissei Pharmaceutical Marks 80th Anniversary With Special Dividends and Higher Payout
6M ago
Kissei Pharmaceutical Releases Supplementary Materials on Nine-Month FY2025 Results and R&D Pipeline
PremiumCompany Announcements
Kissei Pharmaceutical Releases Supplementary Materials on Nine-Month FY2025 Results and R&D Pipeline
6M ago
Kissei Pharmaceutical Lifts Sales and Earnings, Boosts Payouts Despite Operating Loss
PremiumCompany Announcements
Kissei Pharmaceutical Lifts Sales and Earnings, Boosts Payouts Despite Operating Loss
6M ago
Kissei Pharmaceutical Co (KSPHF) Q3 Earnings Cheat Sheet
PremiumPre-EarningsKissei Pharmaceutical Co (KSPHF) Q3 Earnings Cheat Sheet
6M ago
Kissei Wins Japan Approval for Oral GnRH Antagonist Yselty for Uterine Fibroids
Premium
Company Announcements
Kissei Wins Japan Approval for Oral GnRH Antagonist Yselty for Uterine Fibroids
7M ago
Kissei Pharmaceutical initiated with a Neutral at UBS
Premium
The Fly
Kissei Pharmaceutical initiated with a Neutral at UBS
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >